Literature DB >> 30828793

Perception of impact of Dravet syndrome on children and caregivers in multiple countries: looking beyond seizures.

Rima Nabbout1, Stephane Auvin2, Catherine Chiron1, Elizabeth Thiele3, Helen Cross4, Ingrid E Scheffer5,6, Amy L Schneider5, Renzo Guerrini7, Nicola Williamson8.   

Abstract

AIM: To assess the relevance and generalizability across countries of concepts of the impact of Dravet syndrome beyond seizures, as recognized by families.
METHOD: Caregivers of children with Dravet syndrome in four countries (Australia [n=8]; USA, UK, and Italy [all n=4]) participated in 1-hour qualitative telephone interviews, identifying key Dravet syndrome concepts. Interviews were recorded, transcribed, and, where necessary, translated into English for thematic analysis. Conceptual saturation was assessed and findings compared to the previously developed French conceptual disease model.
RESULTS: The most common seizure types reported by caregivers were tonic-clonic, absence, or focal-impaired awareness (localized/partial). Fever and physical activity were the most commonly reported triggers. Patient-relevant impacts included impairment in cognition, motor skills, communication, social skills, and behavioural functioning. Caregivers consistently reported negative social, physical, and family impacts. Concepts identified in the interviews showed similarity with the French conceptual model. Minor differences between countries are likely to reflect variations in health care systems.
INTERPRETATION: Findings in Italy, Australia, UK, and USA confirm that the key impacts of Dravet syndrome on children and caregivers identified in France are generalizable across countries. Key symptom and impact concepts relevant to children and parents should be targeted as critical outcomes in new therapy evaluations. WHAT THIS PAPER ADDS: Relevance of the impact of Dravet syndrome on children and caregivers was confirmed across countries. Patient and caregiver-relevant Dravet syndrome impacts contribute to poorer health-related quality of life. Indirect seizure impacts were reported to be as important as direct impacts. Country-specific differences in concepts probably reflect differences in health care systems.
© 2019 Mac Keith Press.

Entities:  

Mesh:

Year:  2019        PMID: 30828793     DOI: 10.1111/dmcn.14186

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  6 in total

Review 1.  Dravet Syndrome: Novel Approaches for the Most Common Genetic Epilepsy.

Authors:  Lori L Isom; Kelly G Knupp
Journal:  Neurotherapeutics       Date:  2021-08-10       Impact factor: 6.088

Review 2.  Natural History Studies and Clinical Trial Readiness for Genetic Developmental and Epileptic Encephalopathies.

Authors:  Elizabeth E Palmer; Katherine Howell; Ingrid E Scheffer
Journal:  Neurotherapeutics       Date:  2021-10-27       Impact factor: 6.088

3.  Exploring the relationships between composite scores of disease severity, seizure-freedom and quality of life in Dravet syndrome.

Authors:  Adam Strzelczyk; Gerhard Kurlemann; Thomas Bast; Ulrich Bettendorf; Gerhard Kluger; Thomas Mayer; Bernd A Neubauer; Tilman Polster; Sarah von Spiczak; Regina Trollmann; Markus Wolff; Toby Toward; Jens Gruenert; Eddie Gibson; Clive Pritchard; Joe Carroll; Felix Rosenow; Susanne Schubert-Bast
Journal:  Neurol Res Pract       Date:  2022-06-06

Review 4.  Recent Advances in the Drug Treatment of Dravet Syndrome.

Authors:  Elaine C Wirrell; Rima Nabbout
Journal:  CNS Drugs       Date:  2019-09       Impact factor: 5.749

5.  Dravet Syndrome-The Polish Family's Perspective Study.

Authors:  Justyna Paprocka; Anita Lewandowska; Piotr Zieliński; Bartłomiej Kurczab; Ewa Emich-Widera; Tomasz Mazurczak
Journal:  J Clin Med       Date:  2021-04-28       Impact factor: 4.241

6.  Improving early diagnosis of rare diseases using Natural Language Processing in unstructured medical records: an illustration from Dravet syndrome.

Authors:  Tommaso Lo Barco; Mathieu Kuchenbuch; Nicolas Garcelon; Antoine Neuraz; Rima Nabbout
Journal:  Orphanet J Rare Dis       Date:  2021-07-13       Impact factor: 4.123

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.